Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis

Early lung-specific response to atezolizumab plus bevacizumab was associated with longer overall survival in patients with hepatocellular carcinoma with pulmonary metastases.

Related Keywords

South Korea ,Korea , ,Elimination Of Cancer Project Fund ,Ministry Of Science ,Asan Cancer Institute Of Medical Center ,National Research Foundation Of Korea ,Science Research Program ,International Liver Cancer Association Conference ,Liver Cancer Association ,Child Pugh ,Basic Science Research Program ,National Research Foundation ,Cancer Project Fund ,Asan Cancer Institute ,Masan Medical ,International Liver Cancer Association Annual Conference ,News ,Gastrointestinal Cancer ,Conference ,Atezolizumab ,Tecentriq ,Bevacizumab ,Avastin ,Hepatocellular Carcinoma ,Hcc ,